To identify and address specific oncology outcomes research issues and to develop recommendations to address these issues.


The field of oncology outcomes research is complicated by the diversity of diseases within oncology, the rapidly changing nature of treatments, and the complexities of measuring cost, and quality of life - patient reported outcomes. As such, oncology outcomes research constitutes a unique segment of outcomes research, one that requires specific clinical and methodological knowledge for its proper conduct.

Working Groups:

Key Project

Oncology Health Economic Modeling Post-Progression


  • Noémi Muszbek, MSc, BSc, Senior Research Scientist, Evidera, Inc, London, England, UK
  • Khalid Kamal, PhD, MPharm, Professor, Pharmacy Administration, School of Pharmacy, Duquesne University, Pittsburgh, PA, USA
  • Sorrel Wolowacz, PhD, Head, EU Health Economics, RTI Health Solutions, Manchester, England, UK

Work Products

  1. A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now